Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva to Launch New Growth Strategy at Investor Day | Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm –